Thédrez P - Search Results

1

Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Saï-Maurel C, Campion L, Faivre-Chauvet A, Mirallié E, Chérel M, Supiot S, Barbet J, Chatal JF, Thédrez P. Kraeber-Bodéré F, et al. Among authors: thedrez p. Mol Cancer Ther. 2002 Feb;1(4):267-74. Mol Cancer Ther. 2002. PMID: 12467222

2

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.

Mirallié E, Saï-Maurel C, Faivre-Chauvet A, Regenet N, Chang CH, Goldenberg DM, Chatal JF, Barbet J, Thedrez P. Mirallié E, et al. Among authors: thedrez p. Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):901-9. doi: 10.1007/s00259-005-1811-2. Epub 2005 Apr 30. Eur J Nucl Med Mol Imaging. 2005. PMID: 15864584

3

Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.

Devys A, Thedrez P, Gautherot E, Faivre-Chauvet A, Saï-Maurel C, Rouvier E, Auget JL, Barbet J, Chatal JF. Devys A, et al. Among authors: thedrez p. Int J Cancer. 1996 Sep 17;67(6):883-91. doi: 10.1002/(SICI)1097-0215(19960917)67:6<883::AID-IJC20>3.0.CO;2-1. Int J Cancer. 1996. PMID: 8824563

4

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Faibre-Chauvet A, Saï-Maurel C, Gautherot E, Fiche M, Campion L, Le Boterff J, Barbet J, Chatal JF, Thédrez P. Kraeber-Bodéré F, et al. Among authors: thedrez p. J Nucl Med. 1999 Jan;40(1):198-204. J Nucl Med. 1999. PMID: 9935077 Free article.

5

Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.

Kraeber-Bodéré F, Faivre-Chauvet A, Saï-Maurel C, Campion L, Fiche M, Gautherot E, Le Boterff J, Barbet J, Chatal JF, Thédrez P. Kraeber-Bodéré F, et al. Among authors: thedrez p. Clin Cancer Res. 1999 Oct;5(10 Suppl):3183s-3189s. Clin Cancer Res. 1999. PMID: 10541362

6

Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation.

Bardiès M, Thedrez P, Gestin JF, Marcille BM, Guerreau D, Faivre-Chauvet A, Mahé M, Sai-Maurel C, Chatal JF. Bardiès M, et al. Among authors: thedrez p. Int J Cancer. 1992 Apr 1;50(6):984-91. doi: 10.1002/ijc.2910500627. Int J Cancer. 1992. PMID: 1555897

7

A new tumor-associated antigen expressed on breast carcinomas, defined by monoclonal antibody BCA 227.

Blottière HM, Pelhate S, Aubry J, Kremer M, Thedrez P, Sai-Maurel C, Douillard JY, Chatal JF. Blottière HM, et al. Among authors: thedrez p. Cancer Res. 1991 Mar 1;51(5):1537-43. Cancer Res. 1991. PMID: 1997195

8

Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination.

Imbert-Marcille BM, Thédrez P, Saï-Maurel C, François C, Auget JL, Benard J, Jacques Y, Imai S, Chatal JF. Imbert-Marcille BM, et al. Among authors: thedrez p. Int J Cancer. 1994 May 1;57(3):392-8. doi: 10.1002/ijc.2910570317. Int J Cancer. 1994. PMID: 8169001

9

Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.

Faivre-Chauvet A, Gestin JF, Mease RC, Sai-Maurel C, Thédrez P, Slinkin M, Meinken GE, Srivastava SC, Chatal JF. Faivre-Chauvet A, et al. Among authors: thedrez p. Nucl Med Biol. 1993 Aug;20(6):763-71. doi: 10.1016/0969-8051(93)90163-o. Nucl Med Biol. 1993. PMID: 8401377

10

Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.

Kraeber-Bodéré F, Mishra A, Thédrez P, Faivre-Chauvet A, Bardiès M, Imai S, Le Boterff J, Chatal JF. Kraeber-Bodéré F, et al. Among authors: thedrez p. Eur J Nucl Med. 1996 May;23(5):560-7. doi: 10.1007/BF00833392. Eur J Nucl Med. 1996. PMID: 8698062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters